Despite the limited mechanistic evidence, there are reports that targeting CDD repair (such as through inhibitors against ATM, PARP and potentially HDACs) can exacerbate the effects of high-LET radiation in promoting tumour cell killing. The gene discussed is PARP1; the disease is neoplasm.